Scarica l'app Stockscreener
15.95
3.63%
-0.60
Dopo l'orario di chiusura:
15.77
-0.18
-1.13%
Precedente Chiudi:
$16.55
Aprire:
$16.55
Volume 24 ore:
38,050
Relative Volume:
0.95
Capitalizzazione di mercato:
$306.42M
Reddito:
$54,000
Utile/perdita netta:
$-210.26M
Rapporto P/E:
-20.19
EPS:
-0.79
Flusso di cassa netto:
$-159.01M
1 W Prestazione:
-4.55%
1M Prestazione:
-10.14%
6M Prestazione:
+72.92%
1 anno Prestazione:
-37.20%
Intervallo 1D:
$15.72
$17.75
Intervallo di 1 settimana:
$15.72
$17.75
Portata 52W:
$7.65
$30.00
Lyell Immunopharma Inc Stock (LYEL) Company Profile
Nome
Lyell Immunopharma Inc
Settore
Industria
Telefono
650 695-0677
Indirizzo
201 HASKINS WAY, SOUTH SAN FRANCISCO
Confronta LYEL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LYEL
Lyell Immunopharma Inc
|
15.95 | 317.95M | 54,000 | -210.26M | -159.01M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lyell Immunopharma Inc Stock (LYEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-30 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-06-27 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-08-28 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-11-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-11-11 | Downgrade | Goldman | Buy → Neutral |
| 2022-10-17 | Iniziato | H.C. Wainwright | Buy |
| 2021-07-12 | Iniziato | BofA Securities | Buy |
| 2021-07-12 | Iniziato | Goldman | Buy |
| 2021-07-12 | Iniziato | JP Morgan | Overweight |
| 2021-07-12 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Lyell Immunopharma Inc Borsa (LYEL) Ultime notizie
Lyell’s dual-targeting CAR T-cell therapy shows promise in lymphoma - Investing.com Australia
How to manage a losing position in Lyell Immunopharma Inc.2025 Retail Activity & Stock Market Timing Techniques - newser.com
How institutional ownership impacts Lyell Immunopharma Inc. stockTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Strategies to average down on Lyell Immunopharma Inc.Weekly Loss Report & Consistent Return Investment Signals - newser.com
Published on: 2025-11-04 03:36:30 - newser.com
How Lyell Immunopharma Inc. stock performs in weak economyGap Up & Breakout Confirmation Trade Signals - newser.com
Will Lyell Immunopharma Inc. benefit from macro trendsWeekly Profit Analysis & High Return Stock Watch Alerts - newser.com
Is Lyell Immunopharma Inc. stock attractive for retirement portfoliosTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
Is Lyell Immunopharma Inc. stock overvalued by current metricsTrade Analysis Report & Expert Verified Stock Movement Alerts - newser.com
Lyell Immunopharma Appoints New Financial Leadership Team - TipRanks
Lyell (Nasdaq: LYEL) to present Phase 1/2 ronde-cel LBCL at ASH; FDA RMAT & Fast Track - Stock Titan
Lyell Immunopharma Announces Key Management Appointments - TradingView
[8-K] Lyell Immunopharma, Inc. Reports Material Event | LYEL SEC FilingForm 8-K - Stock Titan
Volatility clustering patterns for Lyell Immunopharma Inc.July 2025 Drop Watch & Stepwise Trade Execution Plans - newser.com
Real time social sentiment graph for Lyell Immunopharma Inc.2025 Momentum Check & Stock Portfolio Risk Management - newser.com
What hedge fund activity signals for Lyell Immunopharma Inc. stockProfit Target & Risk Controlled Swing Alerts - newser.com
Is this a good reentry point in Lyell Immunopharma Inc.Trade Risk Report & Low Drawdown Trading Techniques - newser.com
Tick level data insight on Lyell Immunopharma Inc. volatilityTrade Analysis Summary & Safe Capital Allocation Plans - newser.com
How to track smart money flows in Lyell Immunopharma Inc.July 2025 Update & Trade Opportunity Analysis - newser.com
Technical signs of recovery in Lyell Immunopharma Inc.2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Published on: 2025-10-31 03:26:35 - newser.com
Is it too late to sell Lyell Immunopharma Inc.Portfolio Gains Report & Weekly Stock Performance Updates - newser.com
Is Lyell Immunopharma Inc. still worth holding after the dipWeekly Profit Recap & Precise Swing Trade Entry Alerts - newser.com
Published on: 2025-10-30 06:17:45 - newser.com
Lyell Immunopharma (LYEL) to Release Quarterly Earnings on Thursday - MarketBeat
Published on: 2025-10-30 02:39:25 - newser.com
[Form 4] Lyell Immunopharma, Inc. Insider Trading Activity - Stock Titan
Published on: 2025-10-28 05:46:43 - newser.com
Lyell Immunopharma Inc Azioni (LYEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.45%
0.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):